ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Elvanse 50 mg, Kapseln - 30 Kapsel(n)
63023002 PPTakeda Pharma AG
Elvanse 50 mg, Kapseln27.03.2014
  27.03.2014
Lisdexamfetamine (N06BA12) 
WHO-DDD 
01.10.20.30 Kapsel(n)
01.10.20. 
A+  
Yes 
IPCI
99.69Yes
    
10 %130.95
7680630230027Synthetika
6009350 
Composition
lisdexamfetamini dimesilas 50 mg corresp. dexamfetaminum 14.8 mg, cellulosum microcristallinum, carmellosum natricum conexum, magnesii stearas, Kapselhülle: gelatina, E 133, E 171, Drucktinte: lacca, propylenglycolum, kalii hydroxidum, E 172 (nigrum), pro capsula corresp. natrium 0.2699 mg.
Packungsbestandteile
Capsules 
  
 
Active AgentDose
Lisdexamfetamini Dimesilas50 mg correspond Dexamfetaminum 14.8 mg
BAG: Active AgentDose
Lisdexamfetamini Dimesilas50 mg
 
Inactive agents additional_information
(Nigrum)  
Carmellosum Natricum Conexum  
Cellulosum Microcristallinum  
E 133 color.
E 171 color.
E 172 color.
Gelatina Kapselhülle
Kalii Hydroxidum  
Lacca Drucktinte
Magnesii Stearas  
Propylenglycol  
 
Source
Data was imported : 05.09.2023 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2024 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home